Skip to main content
Erschienen in: Journal of Radiation Oncology 3-4/2020

25.08.2020 | Original Research

Whole breast irradiation with high tangents in the prone position

verfasst von: Fauzia Shaikh, Moses Tam, Sameer Taneja, Nelly Huppert, Allison McCarthy, Christine Hitchen, Olivier Maisonet, Carmen Perez, David Barbee, Naamit Kurshan Gerber

Erschienen in: Journal of Radiation Oncology | Ausgabe 3-4/2020

Einloggen, um Zugang zu erhalten

Abstract

Objective

Extending the superior border of the breast tangent fields to include the low axilla is a technique employed to target the axillary lymph node (LN) without adding additional fields. This technique, commonly referred to as high tangents, is typically done in the supine position. The feasibility of delivering high tangents in the prone position has never been reported.

Methods

Patients from 2012 to 2018 at a single institution who were prescribed treatment with high tangents using two tangentially opposed beams in the prone position were identified. The levels I–III axillary LNs were retrospectively contoured. The dose delivered to the LN, breast, and organs at risk was calculated using the original treatment plan. For LN, coverage was defined as > 90% of the prescribed dose.

Results

Forty-one patients treated with high tangents were identified. The median age was 62. Most patients underwent sentinel LN biopsy (88%), of which 59% had macroscopic disease and 30% had micrometastatic disease. Four patients had no axillary staging. Most patients (76%) were treated with hypofractionated radiation. The median distance from the superior border of the anterior oblique field to the humeral head was 0.6 cm (range: 0–1.5 cm). The mean coverage of the level I and level II axilla was 88.7% and 40.0% respectively. Axillary level I coverage for distance from the humeral head < 1 cm was 95.1%, whereas distance > 1 cm was 76.4% (p = 0.017).

Conclusions

This series demonstrates the feasibility of high tangents in the prone position, offering good coverage of level I LN, particularly with < 1 cm distance from the humeral head.
Literatur
1.
Zurück zum Zitat Krag DN, Anderson SJ, Julian TB, Brown AM, Harlow SP, Costantino JP, Ashikaga T, Weaver DL, Mamounas EP, Jalovec LM (2010) Sentinel-lymph-node resection compared with conventional axillary-lymph-node dissection in clinically node-negative patients with breast cancer: overall survival findings from the NSABP B-32 randomised phase 3 trial. Lancet Oncol 11(10):927–933PubMedPubMedCentralCrossRef Krag DN, Anderson SJ, Julian TB, Brown AM, Harlow SP, Costantino JP, Ashikaga T, Weaver DL, Mamounas EP, Jalovec LM (2010) Sentinel-lymph-node resection compared with conventional axillary-lymph-node dissection in clinically node-negative patients with breast cancer: overall survival findings from the NSABP B-32 randomised phase 3 trial. Lancet Oncol 11(10):927–933PubMedPubMedCentralCrossRef
2.
Zurück zum Zitat Giuliano AE, Ballman K, McCall L, Beitsch P, Whitworth PW, Blumencranz P, Leitch AM, Saha S, Morrow M, Hunt KK (2016) Locoregional recurrence after sentinel lymph node dissection with or without axillary dissection in patients with sentinel lymph node metastases: long-term follow-up from the American College of Surgeons Oncology Group (Alliance) ACOSOG Z0011 randomized trial. Ann Surg 264(3):413PubMedPubMedCentralCrossRef Giuliano AE, Ballman K, McCall L, Beitsch P, Whitworth PW, Blumencranz P, Leitch AM, Saha S, Morrow M, Hunt KK (2016) Locoregional recurrence after sentinel lymph node dissection with or without axillary dissection in patients with sentinel lymph node metastases: long-term follow-up from the American College of Surgeons Oncology Group (Alliance) ACOSOG Z0011 randomized trial. Ann Surg 264(3):413PubMedPubMedCentralCrossRef
3.
Zurück zum Zitat Whelan TJ, Olivotto IA, Parulekar WR, Ackerman I, Chua BH, Nabid A, Vallis KA, White JR, Rousseau P, Fortin A (2015) Regional nodal irradiation in early-stage breast cancer. N Engl J Med 373(4):307–316PubMedPubMedCentralCrossRef Whelan TJ, Olivotto IA, Parulekar WR, Ackerman I, Chua BH, Nabid A, Vallis KA, White JR, Rousseau P, Fortin A (2015) Regional nodal irradiation in early-stage breast cancer. N Engl J Med 373(4):307–316PubMedPubMedCentralCrossRef
4.
Zurück zum Zitat Poortmans PM, Collette S, Kirkove C, Van Limbergen E, Budach V, Struikmans H, Collette L, Fourquet A, Maingon P, Valli M (2015) Internal mammary and medial supraclavicular irradiation in breast cancer. N Engl J Med 373(4):317–327PubMedCrossRef Poortmans PM, Collette S, Kirkove C, Van Limbergen E, Budach V, Struikmans H, Collette L, Fourquet A, Maingon P, Valli M (2015) Internal mammary and medial supraclavicular irradiation in breast cancer. N Engl J Med 373(4):317–327PubMedCrossRef
5.
Zurück zum Zitat Haffty BG, Hunt KK, Harris JR, Buchholz TA (2011) Positive sentinel nodes without axillary dissection: implications for the radiation oncologist. J Clin Oncol 29(34):4479–4481PubMedCrossRef Haffty BG, Hunt KK, Harris JR, Buchholz TA (2011) Positive sentinel nodes without axillary dissection: implications for the radiation oncologist. J Clin Oncol 29(34):4479–4481PubMedCrossRef
6.
Zurück zum Zitat Specht MC, Kattan MW, Gonen M, Fey J, Van Zee KJ (2005) Predicting nonsentinel node status after positive sentinel lymph biopsy for breast cancer: clinicians versus nomogram. Ann Surg Oncol 12(8):654–659PubMedCrossRef Specht MC, Kattan MW, Gonen M, Fey J, Van Zee KJ (2005) Predicting nonsentinel node status after positive sentinel lymph biopsy for breast cancer: clinicians versus nomogram. Ann Surg Oncol 12(8):654–659PubMedCrossRef
7.
Zurück zum Zitat Mittendorf EA, Hunt KK, Boughey JC, Bassett R, Degnim AC, Harrell R, Yi M, Meric-Bernstam F, Ross MI, Babiera GV (2012) Incorporation of sentinel lymph node metastasis size into a nomogram predicting non-sentinel lymph node involvement in breast cancer patients with a positive sentinel lymph node. Ann Surg 255(1):109–115PubMedPubMedCentralCrossRef Mittendorf EA, Hunt KK, Boughey JC, Bassett R, Degnim AC, Harrell R, Yi M, Meric-Bernstam F, Ross MI, Babiera GV (2012) Incorporation of sentinel lymph node metastasis size into a nomogram predicting non-sentinel lymph node involvement in breast cancer patients with a positive sentinel lymph node. Ann Surg 255(1):109–115PubMedPubMedCentralCrossRef
8.
Zurück zum Zitat Jagsi R, Chadha M, Moni J, Ballman K, Laurie F, Buchholz TA, Giuliano A, Haffty BG (2014) Radiation field design in the ACOSOG Z0011 (Alliance) trial. J Clin Oncol 32(32):3600–3606PubMedPubMedCentralCrossRef Jagsi R, Chadha M, Moni J, Ballman K, Laurie F, Buchholz TA, Giuliano A, Haffty BG (2014) Radiation field design in the ACOSOG Z0011 (Alliance) trial. J Clin Oncol 32(32):3600–3606PubMedPubMedCentralCrossRef
9.
Zurück zum Zitat Azghadi S, Daly M, Mayadev J (2015) Practice patterns of radiation field design for sentinel lymph node positive early-stage breast cancer. Int J Radiat Oncol Biol Phys 93(3):E17–E18CrossRef Azghadi S, Daly M, Mayadev J (2015) Practice patterns of radiation field design for sentinel lymph node positive early-stage breast cancer. Int J Radiat Oncol Biol Phys 93(3):E17–E18CrossRef
10.
Zurück zum Zitat Gebhardt BJ, Thomas J, Horne ZD, Champ CE, Ahrendt GM, Diego E, Heron DE, Beriwal S (2018) Standardization of nodal radiation therapy through changes to a breast cancer clinical pathway throughout a large, integrated cancer center network. Pract Radiat Oncol 8(1):4–12PubMedCrossRef Gebhardt BJ, Thomas J, Horne ZD, Champ CE, Ahrendt GM, Diego E, Heron DE, Beriwal S (2018) Standardization of nodal radiation therapy through changes to a breast cancer clinical pathway throughout a large, integrated cancer center network. Pract Radiat Oncol 8(1):4–12PubMedCrossRef
11.
Zurück zum Zitat Formenti SC, DeWyngaert JK, Jozsef G, Goldberg JD (2012) Prone vs supine positioning for breast cancer radiotherapy. JAMA 308(9):861–863PubMedCrossRef Formenti SC, DeWyngaert JK, Jozsef G, Goldberg JD (2012) Prone vs supine positioning for breast cancer radiotherapy. JAMA 308(9):861–863PubMedCrossRef
12.
Zurück zum Zitat Stegman LD, Beal KP, Hunt MA, Fornier MN, McCormick B (2007) Long-term clinical outcomes of whole-breast irradiation delivered in the prone position. Int J Radiat Oncol Biol Phys 68(1):73–81PubMedCrossRef Stegman LD, Beal KP, Hunt MA, Fornier MN, McCormick B (2007) Long-term clinical outcomes of whole-breast irradiation delivered in the prone position. Int J Radiat Oncol Biol Phys 68(1):73–81PubMedCrossRef
13.
Zurück zum Zitat Alonso-Basanta M, Ko J, Babcock M, Dewyngaert JK, Formenti SC (2009) Coverage of axillary lymph nodes in supine vs. prone breast radiotherapy. Int J Radiat Oncol Biol Phys 73(3):745–751PubMedCrossRef Alonso-Basanta M, Ko J, Babcock M, Dewyngaert JK, Formenti SC (2009) Coverage of axillary lymph nodes in supine vs. prone breast radiotherapy. Int J Radiat Oncol Biol Phys 73(3):745–751PubMedCrossRef
14.
Zurück zum Zitat MacDermed DM, Houtman KM, Thang SH, Allen PK, Caudle AS, Gainer SM, Hunt KK, Perkins GH, Shaitelman SF, Smith BD (2014) Therapeutic radiation dose delivered to the low axilla during whole breast radiation therapy in the prone position: implications for targeting the undissected axilla. Pract Radiat Oncol 4(2):116–122PubMedCrossRef MacDermed DM, Houtman KM, Thang SH, Allen PK, Caudle AS, Gainer SM, Hunt KK, Perkins GH, Shaitelman SF, Smith BD (2014) Therapeutic radiation dose delivered to the low axilla during whole breast radiation therapy in the prone position: implications for targeting the undissected axilla. Pract Radiat Oncol 4(2):116–122PubMedCrossRef
15.
Zurück zum Zitat DeWyngaert JK, Jozsef G, Mitchell J, Rosenstein B, Formenti SC (2007) Accelerated intensity-modulated radiotherapy to breast in prone position: dosimetric results. Int J Radiat Oncol Biol Phys 68(4):1251–1259PubMedCrossRef DeWyngaert JK, Jozsef G, Mitchell J, Rosenstein B, Formenti SC (2007) Accelerated intensity-modulated radiotherapy to breast in prone position: dosimetric results. Int J Radiat Oncol Biol Phys 68(4):1251–1259PubMedCrossRef
16.
Zurück zum Zitat Lymberis SC, Dewyngaert JK, Parhar P, Chhabra AM, Fenton-Kerimian M, Chang J, Hochman T, Guth A, Roses D, Goldberg JD (2012) Prospective assessment of optimal individual position (prone versus supine) for breast radiotherapy: volumetric and dosimetric correlations in 100 patients. Int J Radiat Oncol Biol Phys 84(4):902–909PubMedCrossRef Lymberis SC, Dewyngaert JK, Parhar P, Chhabra AM, Fenton-Kerimian M, Chang J, Hochman T, Guth A, Roses D, Goldberg JD (2012) Prospective assessment of optimal individual position (prone versus supine) for breast radiotherapy: volumetric and dosimetric correlations in 100 patients. Int J Radiat Oncol Biol Phys 84(4):902–909PubMedCrossRef
17.
Zurück zum Zitat White J, Tai A, Arthur D, Buchholz T, MacDonald S, Marks L, Pierce L, Racht A, Rabinovitch R, Taghian AJP, PA: RTOG (2009) Breast cancer atlas for radiation therapy planning: consensus definitions White J, Tai A, Arthur D, Buchholz T, MacDonald S, Marks L, Pierce L, Racht A, Rabinovitch R, Taghian AJP, PA: RTOG (2009) Breast cancer atlas for radiation therapy planning: consensus definitions
18.
Zurück zum Zitat Schlembach PJ, Buchholz TA, Ross MI, Kirsner SM, Salas GJ, Strom EA, McNeese MD, Perkins GH, Hunt KK (2001) Relationship of sentinel and axillary level I–II lymph nodes to tangential fields used in breast irradiation. Int J Radiat Oncol Biol Phys 51(3):671–678PubMedCrossRef Schlembach PJ, Buchholz TA, Ross MI, Kirsner SM, Salas GJ, Strom EA, McNeese MD, Perkins GH, Hunt KK (2001) Relationship of sentinel and axillary level I–II lymph nodes to tangential fields used in breast irradiation. Int J Radiat Oncol Biol Phys 51(3):671–678PubMedCrossRef
19.
Zurück zum Zitat Reed DR, Lindsley SK, Mann GN, Austin-Seymour M, Korssjoen T, Anderson BO, Moe R (2005) Axillary lymph node dose with tangential breast irradiation. Int J Radiat Oncol Biol Phys 61(2):358–364PubMedCrossRef Reed DR, Lindsley SK, Mann GN, Austin-Seymour M, Korssjoen T, Anderson BO, Moe R (2005) Axillary lymph node dose with tangential breast irradiation. Int J Radiat Oncol Biol Phys 61(2):358–364PubMedCrossRef
20.
Zurück zum Zitat Reznik J, Cicchetti MG, Degaspe B, Fitzgerald TJ (2005) Analysis of axillary coverage during tangential radiation therapy to the breast. Int J Radiat Oncol Biol Phys 61(1):163–168PubMedCrossRef Reznik J, Cicchetti MG, Degaspe B, Fitzgerald TJ (2005) Analysis of axillary coverage during tangential radiation therapy to the breast. Int J Radiat Oncol Biol Phys 61(1):163–168PubMedCrossRef
21.
Zurück zum Zitat Nagar H, Zhou L, Biritz B, Sison C, Chang J, Smith M, Nori D, Chao KC, Hayes MK (2014) Is there a tradeoff in using modified high tangent field radiation for treating an undissected node-positive axilla? Clin Breast Cancer 14(2):109–113PubMedCrossRef Nagar H, Zhou L, Biritz B, Sison C, Chang J, Smith M, Nori D, Chao KC, Hayes MK (2014) Is there a tradeoff in using modified high tangent field radiation for treating an undissected node-positive axilla? Clin Breast Cancer 14(2):109–113PubMedCrossRef
22.
Zurück zum Zitat Jacobson G, Bunda-Randall N, Wen S, Miller M (2017) Axillary lymph node coverage with 3-dimensional tangential field irradiation and correlation with heart and lung dose. Adv Radiat Oncol 2(4):630–635PubMedPubMedCentralCrossRef Jacobson G, Bunda-Randall N, Wen S, Miller M (2017) Axillary lymph node coverage with 3-dimensional tangential field irradiation and correlation with heart and lung dose. Adv Radiat Oncol 2(4):630–635PubMedPubMedCentralCrossRef
23.
Zurück zum Zitat Leonard KL, Solomon D, Hepel JT, Hiatt JR, Wazer DE, DiPetrillo TA (2012) Axillary lymph node dose with tangential whole breast radiation in the prone versus supine position: a dosimetric study. Radiat Oncol 7(1):72PubMedPubMedCentralCrossRef Leonard KL, Solomon D, Hepel JT, Hiatt JR, Wazer DE, DiPetrillo TA (2012) Axillary lymph node dose with tangential whole breast radiation in the prone versus supine position: a dosimetric study. Radiat Oncol 7(1):72PubMedPubMedCentralCrossRef
24.
Zurück zum Zitat Shaitelman SF, Schlembach PJ, Arzu I, Ballo M, Bloom ES, Buchholz D, Chronowski GM, Dvorak T, Grade E, Hoffman KE (2015) Acute and short-term toxic effects of conventionally fractionated vs hypofractionated whole-breast irradiation: a randomized clinical trial. JAMA Oncol 1(7):931–941PubMedPubMedCentralCrossRef Shaitelman SF, Schlembach PJ, Arzu I, Ballo M, Bloom ES, Buchholz D, Chronowski GM, Dvorak T, Grade E, Hoffman KE (2015) Acute and short-term toxic effects of conventionally fractionated vs hypofractionated whole-breast irradiation: a randomized clinical trial. JAMA Oncol 1(7):931–941PubMedPubMedCentralCrossRef
25.
Zurück zum Zitat Lipps DB, Sachdev S, Strauss JB (2017) Quantifying radiation dose delivered to individual shoulder muscles during breast radiotherapy. Radiother Oncol 122(3):431–436PubMedPubMedCentralCrossRef Lipps DB, Sachdev S, Strauss JB (2017) Quantifying radiation dose delivered to individual shoulder muscles during breast radiotherapy. Radiother Oncol 122(3):431–436PubMedPubMedCentralCrossRef
Metadaten
Titel
Whole breast irradiation with high tangents in the prone position
verfasst von
Fauzia Shaikh
Moses Tam
Sameer Taneja
Nelly Huppert
Allison McCarthy
Christine Hitchen
Olivier Maisonet
Carmen Perez
David Barbee
Naamit Kurshan Gerber
Publikationsdatum
25.08.2020
Verlag
Springer Berlin Heidelberg
Erschienen in
Journal of Radiation Oncology / Ausgabe 3-4/2020
Print ISSN: 1948-7894
Elektronische ISSN: 1948-7908
DOI
https://doi.org/10.1007/s13566-020-00433-z

Weitere Artikel der Ausgabe 3-4/2020

Journal of Radiation Oncology 3-4/2020 Zur Ausgabe

Alphablocker schützt vor Miktionsproblemen nach der Biopsie

16.05.2024 alpha-1-Rezeptorantagonisten Nachrichten

Nach einer Prostatabiopsie treten häufig Probleme beim Wasserlassen auf. Ob sich das durch den periinterventionellen Einsatz von Alphablockern verhindern lässt, haben australische Mediziner im Zuge einer Metaanalyse untersucht.

Mammakarzinom: Senken Statine das krebsbedingte Sterberisiko?

15.05.2024 Mammakarzinom Nachrichten

Frauen mit lokalem oder metastasiertem Brustkrebs, die Statine einnehmen, haben eine niedrigere krebsspezifische Mortalität als Patientinnen, die dies nicht tun, legen neue Daten aus den USA nahe.

Labor, CT-Anthropometrie zeigen Risiko für Pankreaskrebs

13.05.2024 Pankreaskarzinom Nachrichten

Gerade bei aggressiven Malignomen wie dem duktalen Adenokarzinom des Pankreas könnte Früherkennung die Therapiechancen verbessern. Noch jedoch klafft hier eine Lücke. Ein Studienteam hat einen Weg gesucht, sie zu schließen.

Viel pflanzliche Nahrung, seltener Prostata-Ca.-Progression

12.05.2024 Prostatakarzinom Nachrichten

Ein hoher Anteil pflanzlicher Nahrung trägt möglicherweise dazu bei, das Progressionsrisiko von Männern mit Prostatakarzinomen zu senken. In einer US-Studie war das Risiko bei ausgeprägter pflanzlicher Ernährung in etwa halbiert.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.